Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
ESC Heart Failure
|
November 26, 2025
Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness
Josep Darbà, Meritxell Ascanio, Antonio Rodríguez, et al.
Cardiovascular Drugs and Therapy
|
July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Matteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Thrombosis Research
|
June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Carme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
IJID Regions
|
February 11, 2025
Mortality Associated with Surgical Site Infections Following Cardiac Surgery: Insights from the International ID-IRI Study
Hakan Erdem, Handan Ankarali, Jaffar A Al-Tawfiq, et al.
International Journal of Cardiology
|
December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor
Matteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
ESC Heart Failure
|
November 26, 2025
Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness
Josep Darbà, Meritxell Ascanio, Antonio Rodríguez, et al.
Cardiovascular Drugs and Therapy
|
July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Matteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Thrombosis Research
|
June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Carme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
IJID Regions
|
February 11, 2025
Mortality Associated with Surgical Site Infections Following Cardiac Surgery: Insights from the International ID-IRI Study
Hakan Erdem, Handan Ankarali, Jaffar A Al-Tawfiq, et al.
International Journal of Cardiology
|
December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor
Matteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
Page
of 10